Elsevier Inc.

SHERPA: Unknown

People

  1. Seshan
    Seshan
  2. Aghajanian
    Aghajanian
  3. Hensley
    Hensley
  4. Sabbatini
    Sabbatini
  5. Kris
    Kris
  6. Chi
    Chi
  7. Rusch
    Rusch
  8. Alektiar
    Alektiar
  9. Lee
    Lee
  10. Pfister
    Pfister

Groups

  1. Biostatistics Service (27)
  2. Center for Pancreatic Cancer Research (27)
  3. Department of Medicine (27)
  4. Epidemiology and Biostatistics (27)
  5. Solid Tumor Oncology Division (27)
  6. Surgery (23)
  7. GDMT, Medicine (16)
  8. Gynecologic Medicine Service (16)
  9. Gynecology Disease Management Team (16)
  10. GDMT, Surgery (11)
Search Within
  1. "Venkatraman Seshan"
  2. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (9)
Groups
  1. Biostatistics Service (27)
  2. Center for Pancreatic Cancer Research (27)
  3. Department of Medicine (27)
  4. Epidemiology and Biostatistics (27)
  5. Solid Tumor Oncology Division (27)
  6. Surgery (23)

More Groups

People
  1. Venkatraman Seshan (27)
  2. Richard Barakat (12)
  3. Carol Aghajanian (11)
  4. David Spriggs (8)
  5. Martee Hensley (8)
  6. Paul Sabbatini (8)

More People

Years
  1. 2017 (1)
  2. 2008 (1)
  3. 2007 (7)
  4. 2006 (3)
  5. 2003 (2)
  6. 2002 (3)

More Years

Publications
  1. Gynecologic Oncology (16)
  2. Journal of Thoracic Oncology (6)
  3. International Journal of Radiation Oncology, Biology, Physics (4)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era treated at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Alperovich, A.; Batlevi, C.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; Hamlin, P.; Horwitz, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
    Journal Article

    Marks, J. L.; Broderick, S.; Zhou, Q.; Chitale, D.; Li, A. R.; Zakowski, M. F.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.; Seshan, V. E.; more...
    Journal of Thoracic Oncology (2008)

    Fulltext@MSK | Save
  • Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Riely, G. J.; Seshan, V. E.; Azzoli, C. G.; Kris, M. G.; Rusch, V. W.; Park, B. K.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Salvage re-irradiation for recurrent head and neck cancer
    Journal Article

    Lee, N.; Chan, K.; Bekelman, J. E.; Zhung, J.; Mechalakos, J.; Narayana, A.; Wolden, S.; Venkatraman, E. S.; Pfister, D.; Kraus, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save
  • Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma
    Journal Article

    Krug, L. M.; Heelan, R. T.; Kris, M. G.; Venkatraman, E.; Sirotnak, F. M.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials
    Journal Article

    Harrison, M. L.; Gore, M. E.; Spriggs, D.; Kaye, S.; Iasonos, A.; Hensley, M.; Aghajanian, C.; Venkatraman, E.; Sabbatini, P.
    Gynecologic Oncology (2007)

    Fulltext@MSK | Save
  • A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer
    Journal Article

    Azzoli, C. G.; Krug, L. M.; Miller, V. A.; Rizvi, N. A.; Kris, M. G.; Dunne, M.; Farmer, A.; Pizzo, B.; Tyson, L.; Seeger, T.; more...
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy (IMRT) versus conventional radiotherapy using delayed accelerated concomitant boost (CBRT) for patients with locally advanced oropharyngeal carcinoma
    Meeting Abstract

    Puri, D. R.; Lee, N. Y.; De Arruda, F. F.; Wolden, S. L.; Narayana, A.; Venkatraman, E. S.; Kraus, D. H.; Shah, J. P.; Pfister, D. G.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2006)

    Fulltext@MSK | Save